BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15627024)

  • 1. Recent advances in treatment of primary central nervous system lymphoma.
    Nayak L; Batchelor TT
    Curr Treat Options Oncol; 2013 Dec; 14(4):539-52. PubMed ID: 23934511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnosis and Treatment of Primary CNS Lymphoma.
    von Baumgarten L; Illerhaus G; Korfel A; Schlegel U; Deckert M; Dreyling M
    Dtsch Arztebl Int; 2018 Jun; 115(25):419-426. PubMed ID: 29999484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First line treatments in primary central nervous system lymphomas in young patients.
    Schenone L; Alcantara M; Houillier C; Soussain C
    Curr Opin Oncol; 2023 Sep; 35(5):357-363. PubMed ID: 37498049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma (PCNSL) in older patients.
    Bertucci A; Harlay V; Chinot O; Tabouret E
    Curr Opin Oncol; 2023 Sep; 35(5):373-381. PubMed ID: 37498077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma.
    Ferreri AJM; Calimeri T; Cwynarski K; Dietrich J; Grommes C; Hoang-Xuan K; Hu LS; Illerhaus G; Nayak L; Ponzoni M; Batchelor TT
    Nat Rev Dis Primers; 2023 Jun; 9(1):29. PubMed ID: 37322012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies.
    Holdhoff M; Wagner-Johnston N; Roschewski M
    Onco Targets Ther; 2020; 13():8323-8335. PubMed ID: 32903865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based management of primary and secondary CNS lymphoma.
    Khwaja J; Nayak L; Cwynarski K
    Semin Hematol; 2023 Nov; 60(5):313-321. PubMed ID: 38135609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic, Pathologic, and Therapeutic Considerations for Primary CNS Lymphoma.
    D'Angelo CR
    JCO Oncol Pract; 2024 Feb; 20(2):195-202. PubMed ID: 37967301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a future for maintenance temozolomide chemotherapy in PCNSL?
    Bromberg JEC; Doorduijn JK
    Neuro Oncol; 2023 Apr; 25(4):699-700. PubMed ID: 36655502
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary CNS lymphoma.
    Phillips EH; Fox CP; Cwynarski K
    Curr Hematol Malig Rep; 2014 Sep; 9(3):243-53. PubMed ID: 24969265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab.
    Maximiano Alonso C; Sánchez Ruiz AC; Cantos Sánchez de Ibargüen B; Méndez García M; Ronco IS; Provencio Pulla M
    Clin Transl Oncol; 2010 Oct; 12(10):701-3. PubMed ID: 20947485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma.
    Antonini G; Cox MC; Montefusco E; Ferrari A; Conte E; Morino S; Latino P; Trasimeni G; Monarca B
    J Neurooncol; 2007 Jan; 81(2):197-9. PubMed ID: 16937012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
    Reni M; Ferreri AJ
    Ann Hematol; 2001; 80 Suppl 3():B113-7. PubMed ID: 11757691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of primary central nervous system lymphoma].
    Gonzalez-Aguilar A; Houillier C; Soussain C; Hoang-Xuan K
    Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities in primary CNS lymphoma: A systematic review.
    Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
    Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and management of primary CNS lymphoma.
    Roth P; Korfel A; Martus P; Weller M
    Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in primary CNS lymphoma.
    Hoang-Xuan K; Camilleri-Broët S; Soussain C
    Curr Opin Oncol; 2004 Nov; 16(6):601-6. PubMed ID: 15627024
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.